DOP01: The effect of vedolizumab on CD8 T cell repertoire homogeneity and blood-gut trafficking in patients with inflammatory bowel diseaseECCO’23 Copenhagen 2023
DOP03: Unfermented β-fructan fibres can induce gut inflammation and tumorigenesis in select Inflammatory Bowel Disease patients mediated by gut microbiotaECCO’23 Copenhagen 2023
DOP04: Single cell RNA sequencing reveals a potential role for IFNγ in priming circulating monocytes for intestinal inflammatory function in Crohn’s Disease.ECCO’23 Copenhagen 2023
DOP05: Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patientsECCO’23 Copenhagen 2023
DOP06: Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel diseaseECCO’23 Copenhagen 2023
DOP07: Targeting the canonical WNT signalling pathway as a potential novel therapy in Crohn´s associated fibrosisECCO’23 Copenhagen 2023
DOP08: Cellular and molecular interaction of MAIT in mucosal tissue and their role in inflammatory bowel diseaseECCO’23 Copenhagen 2023
DOP09: Eosinophils exert a pro-inflammatory role in a chronic DSS colitis model without an impact on fibrosisECCO’23 Copenhagen 2023
DOP10: Early intestinal resection in Crohn’s Disease is not associated with severe long-term disease courseECCO’23 Copenhagen 2023
DOP11: A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohortsECCO’23 Copenhagen 2023
DOP12: Validation of radiomics features on MR enterography characterizing inflammation and fibrosis in stricturing Crohn’s diseaseECCO’23 Copenhagen 2023